print this page | email this page
2002 - Catalyst For a Cure (CFC) collaborative research program commences
The first 3-year phase of the Catalyst For a Cure research consortium commenced in 2002. Jointly funded by the Steven and Michele Kirsch Foundation and the Glaucoma Research Foundation, the four principal CFC scientists aim to use recent breakthroughs in neuroscience, molecular biology, genetics and immunology to speed progress of treatment and a possible cure for glaucoma.
According to Dr. Martin Wax, member of the CFC advisory board, “The CFC initiative is doing something nearly unprecedented in the field of medical research. It provides research funding to young, bright scientific minds based solely on their desire and ability to apply their scientific skills to the study of a specific disorder with which they were previously unfamiliar; in this case, glaucoma.”